Advance development and current challenges in nails drug delivery-A review

Authors

  • Navneet Kumar Verma Department of Pharmacy, Kailash Institute of Pharmacy and Management, GIDA, Gorakhpur, U.P. 273209
  • Prabhudutta Panda Department of Pharmacy, Kailash Institute of Pharmacy & Management, Gorakhpur, Uttar Pradesh, India, Pin-273209
  • J. N. Mishra Department of Pharmacy, Kailash Institute of Pharmacy & Management, Gorakhpur, Uttar Pradesh, India, Pin-273209
  • D. K. Vishwakarma Department of Pharmacy, Kailash Institute of Pharmacy & Management, Gorakhpur, Uttar Pradesh, India, Pin-273209
  • A. P. Singh Department of Pharmacy, Kailash Institute of Pharmacy & Management, Gorakhpur, Uttar Pradesh, India, Pin-273209
  • Gulzar Alam Department of Pharmacy, Kailash Institute of Pharmacy & Management, Gorakhpur, Uttar Pradesh, India, Pin-273209

DOI:

https://doi.org/10.7439/ijap.v6i1.3934

Keywords:

polyherbal formulation, anti-diarrhoeals, rat models, percentage inhibition, peristaltic index, efficacy

Abstract

Nails drug delivery system (NDDS) is an important delivery system in mammals, in which their nails are highly affected by the fungal diseases. Disorders of the nail unit range from relatively innocuous conditions such as pigmentation in heavy smokers, to painful and debilitating states where the nail unit can be dystrophied, hypertrophied, inflamed, infected etc. The human nail forms a resistant barrier to the topical penetration of drugs. Thus, treatment of nail disorders, such as fungal infections, remains a challenge because of the difficulty encountered in achieving therapeutic concentrations of drugs at the site of infection, which is often under the nail. Ungual and trans-ungual drug delivery continues to receive significant attention due to the need for efficacious topical therapies for onychomycosis given the potential risk of systemic adverse effects associated with the conventional oral therapy. To successfully treat nail disorders, applied drugs must permeate through the dense keratinized nail plate and reach the deeper layers of the nail plate, nail bed and the nail matrix. Physical, chemical and mechanical methods have been used to decrease the nail barrier. This current review include anatomy of human nail, nails disorders, factors affecting tans-ungual delivery of drugs and methods used for enhancement of drugs penetration into/across the nail.

Downloads

Download data is not yet available.

Author Biography

  • Navneet Kumar Verma, Department of Pharmacy, Kailash Institute of Pharmacy and Management, GIDA, Gorakhpur, U.P. 273209
    pharmaceutics department

References

Murdan S. Drug delivery to the nail following topical application. International journal of pharmaceutics. 2002 Apr 2;236(1):1-26.

Walters KA, Flynn GL, Marvel JR. Physicochemical characterization of the human nail: solvent effects on the permeation of homologous alcohols. Journal of pharmacy and pharmacology. 1985 Nov 1;37(11):771-5.

Prausnitz MR, Langer R. Transdermal drug delivery. Nature biotechnology. 2008 Nov 1;26(11):1261-8.

Hemali B. Gunt, Gerald B. Kasting. Effect of hydration on the permeation of ketoconazole through human nail plate in vitro. Eu. J. Pharma. Sci, 2007; 32: 254

Baran R, Kaoukhov A. Topical antifungal drugs for the treatment of onychomycosis: an overview of current strategies for monotherapy and combination therapy. J. Eur. Acad. Dermatol. Venereol, 2005; 19:21

Tosti A, Piraccini BM. Treatment of common nail disorders. Dermatologic clinics. 2000 Apr 1;18(2):339-48.

James B. Hamilton, Harumi Terada, Gordon E. Mestler; Studies of Growth Throughout the Lifespan in Japanese: Growth And Size of Nails and Their Relationship to Age, Sex, Heredity, and Other Factors. J Gerontol 1955; 10 (4): 401-415. doi: 10.1093/geronj/10.4.401.

LeGros Clark WE, Buxton LHD. Studies in nail growth. Br. J. Dermatol. 1938; 50: 221

Bean WB. 1980. Nail growth. Thirty five years of observation. Arch. Intern. Med. 1980; 140: 73

Geoghegan B, Roberts DF, Sampford MR. A possible climatic effect on nail growth. J. Appl. Physiol. 1958; 13: 135

Hewitt, D, Hillman RW. Relation between rate of nail growth in pregnant women and estimated previous general growth rate. Am. J. Clin. Nutr. 1966; 19: 436

Gilchrist ML, Buxton LD. The relation of finger-nail growth to nutritional status. Journal of anatomy. 1939 Jul;73(Pt 4):575.

Landherr G, Braun-Falco O, Hofmann C, Plewig G, Galosi A. Finger nail growth in patients with psoriasis receiving puva-therapy. Hautarzt. 1982; 33: 210

Sibinga, MS. Observations on growth of fingernails in health and disease. Pediatrics 1959; 24: 225

Dawber RP, Baran R. Structure, embryology, comparative anatomy and physiology of the nail. Baran and Dawber

Lynch MH, O'Guin WM, Hardy C, Mak L, Sun TT. Acidic and basic hair/nail (

Fleckman P. Basic science of the nail unit. Basic Nail Surgery. 1997;3:37-54.

Forslind B. Biophysical studies of the normal nail. Acta Dermato vener 1970; 50: 161

Baden HP, Goldsmith LA, Fleming B. A comparative study of the physicochemical properties of human keratinised tissues. Biochim. Biophys. Acta 1973; 322: 269

Jemec GB, Serup J. Ultrasound structure of the human nail plate. Arch Dermatol 1989;125: 643

Wollina U, Berger M, Karte K. Calculation of nail plate and nail matrix parameters by 20 MHz ultrasounds in healthy volunteers and patients with skin disease. Skin Res Technol 2001;7: 60

Dawber R. The ultrastructure and growth of human nails. Archives of Dermatolo Res.1980; 269:197-204.

Baden HP, Kvedar JC. Biology of nails. Section 4: Biology and function of epidermis and appendages. Dermatology in General Medicine. 1993;1:294-7.

Scher, RK. Onychomycosis is more than a cosmetic problem. Br. J. Dermatol. 1994; 130 (Suppl. 43): 15.

Ghannoum MA, Hajjeh RA, Scher R, Konnikov N, Gupta AK, Summerbell R, Sullivan S, Daniel R, Krusinski P, Fleckman P, Rich P. A large-scale North American study of fungal isolates from nails: the frequency of onychomycosis, fungal distribution, and antifungal susceptibility patterns. Journal of the American Academy of Dermatology. 2000 Oct 31;43(4):641-8.

Roberts DT. Onychomycosis: current treatment and future challenges. BRITISH JOURNAL OF DERMATOLOGY-SUPPLEMENT-. 1999 Nov 1;141:1-4.

Chabasse D, Baran R, De Chauvin MF. Onychomycosis I: epidemiology and etiology. J. de Mycologie Medicale 2000; 10: 177

Pierard G. Onychomycosis and other superficial fungal infections of the foot in the elderly: a Pan-European survey. Dermatology 2001; 202: 220

Debruyne D, Coquerel A. Pharmacokinetics of antifungal agents in onychomycoses. Clin. Pharmacokinet. 2001; 40: 441

Midgley G, Moore MK, Cook JC, Phan QG. Mycology of nail disorders. Journal of the American Academy of Dermatology. 1994 Sep 1;31(3):S68-74.

De Jong EMGJ, Seegers, BAMPA, Gulinck MK, Boezeman JBM, Van de Kerkhof PCM. Psoriasis of the nails associated with disability in a large number of patients: results of a recent interview with 1,728 patients. Dermatology 1996; 193: 300

Shannon H, Wilma F. Diseases of hair and nails. Med Clin N Am. 2009; 93:1195

Walters KA, Flynn GL. Permeability characteristics of the human nail plate. Int. J. Cosmet. Sci., 1983; 231

Mertin D, Lippold BC. In vitro permeability of the human nail and of a keratin membrane from bovine hooves: prediction of the penetration rate of antimycotics through the nail plate and their efficiency. J. Pharm. Pharmacol. 1997; 49: 866

Walters KA, Flynn GL, Marvel JR. Physicochemical characterisation of thehuman nail: solvent effects on the permeation of homologous alcohols. J. Pharm. Pharmacol. 1985; 37: 771

Soong MH. Transport properties of drugs and model compounds across the human nail. PhD dissertation, University of Minnesota; 1991

Gupchup GV, Zatz JL, Structural characteristics and permeability properties of the human nail: a review. J. Cosmet. Sci. 1999; 50: 363

Gupta AK, Scher RK. Oral antifungal agents for onychomycosis. Lancet. 1998; 351: 541

Baran R, Kaoukhov A. Topical antifungal drugs for the treatment of onychomycosis: an overview of current strategies for monotherapy and combination therapy. J. Eur. Acad. Dermatol. Venereol. 2005; 19: 21

Hao J, Li SK. Transungual iontophoretic transport of polar neutral and positively charged model permeants: effects of electrophoresis and electroosmosis. J. Pharm. Sci. 2008; 97: 893

Murthy SN, Wiskirchen DE, Bowers CP. Iontophoretic drug delivery across human nail. J. Pharm. Sci. 2007; 96 305

Pittrof F, Gerhards J, Erni W, Klecak G. Loceryl

Lauharanta J. Comparative efficacy and safety of amorolfine nail lacquer 2- percent versus 5-percent once weekly. Clin. Exp. Dermatol. 1992; 17: 41

Sun Y, Liu JC, Wang JCT, De Doncker P. Nail Penetration. Focus on topical delivery of antifungal drugs for onychomycosis treatment. In: Bronaugh, R.L., Maibach, H.I. (Eds.), Percutaneous Absorption, Drugs-Cosmetics-Mechanisms-Methodology, 3rd ed. Marcel Dekker Inc., New York, 1999, pp. 759

Di Chiacchio N, Kadunc BV, De Almeida AR, Madeira CL. Nail abrasion. J. Cosmet. Dermatol. 2003; 2: 150

Wang JCT, Sun Y. Human nail and its topical treatment: brief review of current research and development of topical antifungal drug delivery for onychomycosis treatment. J. Cosmet. Sci., 1998; 71

Friedrich J, Kern S. Hydrolysis of native proteins by keratinolytic protease of Doratomyces microsporus. J. Mol. Catal. B: Enzym. 2003; 21: 35

Gradisar H, Friedrich J, Krizaj I, Jerala R. Similarities and specificities of fungal keratinolytic proteases: comparison of keratinases of Paecilomyces marquandii and Doratomyces microsporus to some known proteases. Appl. Environ. Microbiol. 2005; 71: 3420

Mohorcic M, Torkar A, Friedrich J, Kristl J, Murdan S. An investigation into keratinolytic enzymes to enhance ungual drug delivery. Int. J. Pharm. 2007; 332: 196

Hui X, Chan TC, Barbadillo S, Lee C, Maibach HI, Wester RC. Enhanced econazole penetration into human nail by 2-n-nonyl-1,3-dioxolane. J. Pharm. Sci. 2003; 92: 142

Kobayashi Y, Miyamoto M, Sugibayashi K, Morimoto Y. Enhancing effect of N- acetyl-l-cysteine or 2-mercaptoethanol on the in vitro permeation of 5-fluorouracil or tolnaftate through the human nail plate. Chem. Pharm. Bull. (Tokyo). 1998; 46: 1797

Hoogdalem EJ, Hoven WE, Terpstra IJ, Zijtveld J, Verschoor JSC, Visser JN. Nail penetration of the antifungal agent oxiconazole after repeated topical application in healthy volunteers, and the effect of acetylcysteine. Eur. J. Pharm. Sci. 1997; 5: 119

Malhotra GG, Zatz JL. Investigation of nail permeation enhancement by chemical modification using water as a probe. J. Pharm. Sci. 2002; 91: 312

Quintanar-Guerrero D, Ganem-Quintanar A, Tapia-Olguin P, Kalia YN, Buri P. The effect of keratolytic agents on the permeability of three imidazole antimycotic drugs through the human nail. Drug Dev. Ind. Pharm. 1998; 24: 685

Brown MB, Khengar RH, Turner RB, Forbes B, Traynor MJ, Evans CR, Jones SA. Overcoming the nail barrier: a systematic investigation of ungual chemical penetration enhancement. Int. J. Pharm. 2009; 370: 61

Murthy SN, Wiskirchen DE, Bowers CP. Iontophoretic drug delivery across human nail. J. Pharm. Sci. 2007; 96: 305

Murthy SN, Waddell DC, Shivakumar HN, Balaji A, Bowers CP. Iontophoretic permselective property of human nail. J. Dermatol. Sci. 2007; 46: 150

Hao J, Li SK. Transungual iontophoretic transport of polar neutral and positively charged model permeants: effects of electrophoresis and electroosmosis. J. Pharm. Sci. 2008; 97: 893

Repka MA, Mididoddi PK, Stodghill SP. Influence of human nail etching for the assessment of topical onychomycosis therapies. Int. J. Pharm. 2004; 282: 95

Mididoddi PK, Prodduturi S, Repka MA. Influence of tartaric acid on the bioadhesion and mechanical properties of hot-melt extruded hydroxypropyl cellulose films for the human nail. Drug Dev. Ind. Pharm. 2006; 32: 1059

Kasting GB, Barai ND, Wang TF, Nitsche JM. Mobility of water in human stratum corneum. J. Pharm. Sci. 2003; 92: 2326

Gunt HB, Kasting GB. Effect of hydration on the permeation of ketoconazole through human nail plate in vitro. Eur. J. Pharm. Sci. 2007; 32: 254

Grover C, Bansal S, Nanda S, Reddy BS, Kumar V. Combination of surgical avulsion and topical therapy for single nail onychomycosis: a randomized controlled trial. Br. J. Dermatol. 2007; 157: 364

Karrell ML. Laser Apparatus for Making Holes and Etchings. USPTO, USA,1999.

Kassan DG, Lynch AM, Stiller MJ. Physical enhancement of dermatologic drug delivery: iontophoresis and phonophoresis. J. Am. Acad. Dermatol. 1996; 34 (4): 657

Maltezos G, Scherer A.Treatment of Toenail Fungus. USPTO, USA. 2005.

Donnelly RF, Mccarron PA, Lightowler JM, Woolfson AD. Bioadhesive patch-based delivery of 5-aminolevulinic acid to the nail for photodynamic therapy of onychomycosis. J. Control. Release 2005; 103: 381

Downloads

Published

2017-01-30

Issue

Section

Review Article

How to Cite

1.
Advance development and current challenges in nails drug delivery-A review. Int J Adv Pharm [Internet]. 2017 Jan. 30 [cited 2024 Sep. 8];6(1):08-16. Available from: https://ssjournals.co.in/index.php/ijap/article/view/3934

Similar Articles

1-10 of 41

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)